Skip to content
The Longevity Archive
Abaloparatide in all countries

Legal status · Australia

Is Abaloparatide legal in Australia?

Approved medicineHormoneEvidence: Strong

Yes. Abaloparatide is an approved medicine in Australia, classified as "TGA-registered, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.

Abaloparatide in Australia at a glance

ClassificationTGA-registered, prescription only
TGA approval statusApproved by TGA for its labeled use
Evidence levelStrong (research strength: Strong)
ReviewedSep 2026

Classification and note come from the Abaloparatide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

  • 01

    TGA has approved Abaloparatide for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.

  • 02

    Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

  • 03

    Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Abaloparatide is

An FDA-approved bone-building peptide analogue of parathyroid hormone-related protein for postmenopausal osteoporosis.

Abaloparatide is a synthetic analogue of parathyroid hormone-related protein, approved as Tymlos to build bone in postmenopausal women at high fracture risk. Like teriparatide it stimulates new bone formation with once-daily injection, and trials showed strong fracture reduction.

Mechanism: Selectively activates the PTH1 receptor to favor bone formation over resorption, increasing bone density.

Regulatory history: FDA-approved (Tymlos) for osteoporosis

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Abaloparatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Abaloparatide in other countries

Frequently asked questions

Is Abaloparatide legal in Australia?

Yes. Abaloparatide is an approved medicine in Australia, classified as "TGA-registered, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.

Can I buy Abaloparatide in Australia?

Only with a prescription. Abaloparatide is classified as "TGA-registered, prescription only" in Australia, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.

Is Abaloparatide TGA approved?

Yes, for its labeled indication. In Australia Abaloparatide is classified as "TGA-registered, prescription only". For comparison, the US FDA status is: FDA-approved (Tymlos) for osteoporosis. Evidence level: Strong.

Related compounds in Australia

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Abaloparatide live on its compound profile.

Abaloparatide profile

This page is general information about the regulatory status of Abaloparatide in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.